Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of “Hold” by Brokerages

Shares of Health Catalyst, Inc. (NASDAQ:HCAT) have earned a consensus recommendation of “Hold” from the thirteen brokerages that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and four have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $2.8409.

A number of analysts recently weighed in on HCAT shares. Stephens lowered their target price on shares of Health Catalyst from $2.00 to $1.75 and set an “equal weight” rating on the stock in a research note on Tuesday, May 12th. Wells Fargo & Company raised their price target on shares of Health Catalyst from $1.00 to $1.75 and gave the stock an “equal weight” rating in a research note on Friday, June 26th. Weiss Ratings restated a “sell (e+)” rating on shares of Health Catalyst in a research note on Wednesday, June 24th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Health Catalyst in a report on Monday, May 11th.

Hedge Funds Weigh In On Health Catalyst

Several hedge funds and other institutional investors have recently modified their holdings of the stock. First Light Asset Management LLC boosted its stake in Health Catalyst by 17.2% in the 2nd quarter. First Light Asset Management LLC now owns 12,230,181 shares of the company’s stock valued at $46,108,000 after buying an additional 1,793,374 shares in the last quarter. Vanguard Group Inc. raised its stake in Health Catalyst by 2.9% during the third quarter. Vanguard Group Inc. now owns 4,295,691 shares of the company’s stock worth $12,243,000 after acquiring an additional 119,117 shares in the last quarter. Whetstone Capital Advisors LLC raised its stake in Health Catalyst by 0.5% during the fourth quarter. Whetstone Capital Advisors LLC now owns 3,750,377 shares of the company’s stock worth $8,963,000 after acquiring an additional 19,027 shares in the last quarter. Nepsis Inc. lifted its holdings in shares of Health Catalyst by 26.6% during the fourth quarter. Nepsis Inc. now owns 1,915,794 shares of the company’s stock valued at $4,579,000 after acquiring an additional 402,762 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in shares of Health Catalyst by 11.4% during the second quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock valued at $6,269,000 after acquiring an additional 169,580 shares during the period. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Trading Down 1.3%

Shares of Health Catalyst stock opened at $2.25 on Friday. The firm has a market capitalization of $166.25 million, a PE ratio of -0.60 and a beta of 1.56. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.69 and a quick ratio of 1.69. The company’s fifty day moving average price is $1.73 and its two-hundred day moving average price is $1.74. Health Catalyst has a 52-week low of $0.96 and a 52-week high of $4.11.

Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings data on Monday, May 11th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.01. The company had revenue of $70.76 million during the quarter, compared to analysts’ expectations of $69.24 million. Health Catalyst had a negative net margin of 87.69% and a negative return on equity of 3.52%. On average, analysts expect that Health Catalyst will post -0.25 EPS for the current year.

About Health Catalyst

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.